Literature DB >> 9538931

Heart failure: is there an energy deficit contributing to contractile dysfunction?

A M Vogt1, W Kübler.   

Abstract

UNLABELLED: Alterations in myocardial energy metabolism have been demonstrated in both animal experiments and clinical observations. Whether these changes contribute to heart failure has been a longstanding and controversial issue. I. The creatine kinase (CK) system and the high energy phosphates under physiological conditions and in acute heart failure: 1. According to in vivo and in vitro experiments the myocardial creatine/creatine phosphate (Cr/CP) system is directly linked to mitochondrial oxidative phosphorylation via the mitochondrial CK. 2. The shift in the mass action ratio of the CK reaction with increasing myocardial oxygen consumption enables marked stimulation of mitochondrial respiratory function via the Cr/CP system with almost maintained free energy of the adenosine triphosphate/adenosine diphosphate (ATP/ADP) system. 3. In acute heart failure the depressed myocardial content mainly of CP can be considered as an adaptive mechanism related to increased oxygen demands. II. The CK system and the high energy phosphates in chronic heart failure: 1. The alterations observed in the CK system in chronic heart failure cannot be interpreted in terms of an "energy deficit" (i.e., the excess of what is spent over what is received on energy). 2. "Energy reserve" (i.e., energy kept back for future use, to fill an emergency) is markedly reduced in heart failure. 3. Under steady state conditions decreased "energy reserve" cannot be expected to contribute to heart failure. Under stress conditions, however, this mechanism is manifest by reducing contractile reserve. 4. The mechanisms by which decreased "energy reserve" induces depression of contractile reserve is not elucidated. III. Heart failure related to alterations in energy metabolism (mitochondrial diseases, stunned, and hibernating myocardium): 1. The phenotype of mitochondrial diseases is predominantly determined by neurological disorders and myopathies. Therefore, the patients are rarely referred to a cardiologist, although the cardiac involvement may ultimately determine the patients' prognosis. 2. Stunned and hibernating myocardium are characterized by prolonged contractile dysfunction in the presence of reversibly damaged myocardium. The underlying mechanisms and its triggers are unknown. INTERPRETATIONS: 1. The reduced energy reserve in heart failure may be considered to contribute to the progression of the disease. 2. As an alternative, however, it can likewise represent a mechanism to protect the endangered myocardium from overload.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538931     DOI: 10.1007/s003950050055

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  9 in total

1.  One day from dyspnea to death--unsuccessful application of extracorporeal membrane oxygenation in toxoplasma myocarditis following bone marrow transplantation.

Authors:  J Hadem; F Schröder; T Winkler; B Gohrbandt; D Fischer; T Korte; H Drexler
Journal:  Clin Res Cardiol       Date:  2006-06-20       Impact factor: 5.460

Review 2.  The management of conditioned nutritional requirements in heart failure.

Authors:  Marc L Allard; Khursheed N Jeejeebhoy; Michael J Sole
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

Review 3.  Electron transport chain defects in heart failure.

Authors:  Jordi Casademont; Oscar Miró
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

4.  Endogenous ghrelin increases in adriamycin-induced heart failure rats.

Authors:  Z Xu; W Wu; X Zhang; G Liu
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

5.  From gene expression profiles to biological validation in enteroviral heart disease.

Authors:  Bobby Yanagawa; Bruce McManus; Zsuzsanna Hollander; Honglin Luo; Raymond Ng; Decheng Yang
Journal:  Exp Clin Cardiol       Date:  2003

6.  Impaired coronary metabolic dilation in the metabolic syndrome is linked to mitochondrial dysfunction and mitochondrial DNA damage.

Authors:  Giacinta Guarini; Takahiko Kiyooka; Vahagn Ohanyan; Yuh Fen Pung; Mario Marzilli; Yeong Renn Chen; Chwen Lih Chen; Patrick T Kang; James P Hardwick; Christopher L Kolz; Liya Yin; Glenn L Wilson; Inna Shokolenko; James G Dobson; Richard Fenton; William M Chilian
Journal:  Basic Res Cardiol       Date:  2016-04-04       Impact factor: 17.165

7.  Administration of exogenous adenosine triphosphate to ischemic skeletal muscle induces an energy-sparing effect: role of adenosine receptors.

Authors:  Claudio Maldonado; Sathnur B Pushpakumar; Gustavo Perez-Abadia; Sengodagounder Arumugam; Andrew N Lane
Journal:  J Surg Res       Date:  2012-07-06       Impact factor: 2.192

Review 8.  Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement.

Authors:  Anna Di Lorenzo; Gabriella Iannuzzo; Alessandro Parlato; Gianluigi Cuomo; Crescenzo Testa; Marta Coppola; Giuseppe D'Ambrosio; Domenico Alessandro Oliviero; Silvia Sarullo; Giuseppe Vitale; Cinzia Nugara; Filippo M Sarullo; Francesco Giallauria
Journal:  J Clin Med       Date:  2020-04-27       Impact factor: 4.241

Review 9.  Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome.

Authors:  Md Ashraful Alam; Md Mahbubur Rahman
Journal:  J Diabetes Metab Disord       Date:  2014-05-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.